Insights

Gene Writing™ Technology Tessera Therapeutics is at the forefront of genome engineering with its innovative Gene Writing™ platform. This cutting-edge technology presents a unique sales opportunity for potential partnerships and collaborations in the biotechnology sector.

Therapeutic Frontiers By aiming to unlock transformative genetic medicines to treat various diseases, Tessera Therapeutics opens doors for sales expansion into the fields of monogenic diseases, cancer, autoimmune disorders, and beyond. This broad therapeutic focus offers diverse market opportunities for sales growth and strategic alliances.

Financial Stability With reported revenues between $10M - $50M and recent funding of $50M, Tessera Therapeutics demonstrates financial health and stability. This positions the company as a reliable partner for potential investors, clients, and collaborators seeking sustainable and long-term sales relationships.

Competitive Positioning In comparison to similar companies like Fulgent Genetics, Beam Therapeutics, and Editas Medicine, Tessera Therapeutics stands out with its unique Gene Writing™ approach and strong financial standing. This competitive edge presents a compelling sales proposition for clients looking for innovative biotechnology solutions.

Market Expansion Located in Somerville, MA, Tessera Therapeutics operates in a vibrant biotech hub, offering opportunities for market expansion and local partnerships. Leveraging this strategic location can enhance sales outreach efforts and foster connections with key players in the industry.

Tessera Therapeutics Tech Stack

Tessera Therapeutics uses 8 technology products and services including Craft CMS, BugHerd, Polyfill, and more. Explore Tessera Therapeutics's tech stack below.

  • Craft CMS
    Content Management System
  • BugHerd
    Issue Trackers
  • Polyfill
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • PHP
    Programming Languages
  • SEOmatic
    Search Engines
  • Tailwind CSS
    UI Frameworks
  • Nginx
    Web Servers

Media & News

Tessera Therapeutics's Email Address Formats

Tessera Therapeutics uses at least 1 format(s):
Tessera Therapeutics Email FormatsExamplePercentage
FLast@tesseratx.comJDoe@tesseratx.com
73%
First.Last@tesseratx.comJohn.Doe@tesseratx.com
23%
First@tesseratx.comJohn@tesseratx.com
3%
Last@tesseratx.comDoe@tesseratx.com
1%

Frequently Asked Questions

Where is Tessera Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Tessera Therapeutics's main headquarters is located at Somerville, MA 02143 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Tessera Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Tessera Therapeutics's official website is tesseratx.com and has social profiles on LinkedIn.

How much revenue does Tessera Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, Tessera Therapeutics's annual revenue reached $35M.

What is Tessera Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Tessera Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tessera Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, Tessera Therapeutics has approximately 340 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: M. S.Chief Scientific Officer: M. H.Chief Operating Officer: H. P.. Explore Tessera Therapeutics's employee directory with LeadIQ.

What industry does Tessera Therapeutics belong to?

Minus sign iconPlus sign icon
Tessera Therapeutics operates in the Biotechnology Research industry.

What technology does Tessera Therapeutics use?

Minus sign iconPlus sign icon
Tessera Therapeutics's tech stack includes Craft CMSBugHerdPolyfillOpen GraphPHPSEOmaticTailwind CSSNginx.

What is Tessera Therapeutics's email format?

Minus sign iconPlus sign icon
Tessera Therapeutics's email format typically follows the pattern of . Find more Tessera Therapeutics email formats with LeadIQ.

How much funding has Tessera Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, Tessera Therapeutics has raised $50M in funding. The last funding round occurred on Dec 18, 2024 for $50M.
Tessera Therapeutics

Tessera Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

Tessera Therapeutics is a biotechnology company pioneering a new approach to genome engineering through the development of its Gene Writing™ and delivery platforms, with the aim to unlock broad new therapeutic frontiers.

Our mission is to cure disease by writing in the code of life. We believe our Gene Writing™ and delivery platforms will enable transformative genetic medicines to treat monogenic diseases, cancer and potentially autoimmune and other diseases.

Discover your future at Tessera.

Section iconCompany Overview

Headquarters
Somerville, MA 02143 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $50M

    Tessera Therapeutics has raised a total of $50M of funding over 4 rounds. Their latest funding round was raised on Dec 18, 2024 in the amount of $50M.

  • $10M$50M

    Tessera Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $50M

    Tessera Therapeutics has raised a total of $50M of funding over 4 rounds. Their latest funding round was raised on Dec 18, 2024 in the amount of $50M.

  • $10M$50M

    Tessera Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.